I have two new stocks and one new ETF for you in this issue. One of the new stocks is Quest Diagnositics (DGX), which is making its debut in the Cabot Value Model. Quest’s stock price has fallen to bargain-basement levels. The company operates in one of the faster growing segments of the healthcare sector, which is one of the better safe-haven sectors when the stock market is falling.
